Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 7, Issue 8, Pages 768-773Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00149
Keywords
mTOR; kinase inhibitor; inflammation; collagen induced arthritis model
Categories
Ask authors/readers for more resources
CZ415, a potent ATP-competitive mTOR inhibitor with unprecedented selectivity over any other kinase is described. In addition to a comprehensive characterization of its activities in vitro, in vitro ADME, and in vivo pharmacokinetic data are reported. The suitability of this inhibitor for studying in vivo mTOR biology is demonstrated in a mechanistic mouse model monitoring mTOR proximal downstream phosphorylation signaling. Furthermore, the compound reported here is the first ATP-competitive mTOR inhibitor described to show efficacy in a semitherapeutic collagen induced arthritis (CIA) mouse model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available